Nutritional products including monoglycerides and fatty acids
US-9078846-B2 · Jul 14, 2015 · US
US9433586B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9433586-B2 |
| Application number | US-201414515203-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2014 |
| Priority date | Dec 29, 2010 |
| Publication date | Sep 6, 2016 |
| Grant date | Sep 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
Opening claim text (preview).
What is claimed is: 1. A method of improving tolerance related to feeding in an infant, toddler, or child, the method comprising administering to the infant, toddler or child a nutritional product comprising a fat system having at least 10 wt %, by weight of the fat system, of at least one of a fatty acid component, fatty acid-containing monoglycerides having at least 70% of the fatty acids at the Sn-1 position, and combinations thereof, wherein the fatty acid component includes at least one of free fatty acids, fatty acid salts, and combinations thereof. 2. The method of claim 1 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 3. The method of claim 1 , wherein the fatty acid component is in a form selected from the group consisting of calcium fatty acid salts, magnesium fatty acid salts, and combinations thereof. 4. The method of claim 1 , wherein the fatty acid component comprises less than 15 wt % saturated fatty acids with a chain length of longer than 14 carbon atoms. 5. The method of claim 1 , wherein the fatty acid component is derived from a vegetable oil. 6. The method of claim 5 , wherein the vegetable oil comprises at least one of olive oil, canola oil, corn oil, soybean oil, high oleic safflower oil, and combinations thereof. 7. The method of claim 6 , wherein the vegetable oil is soybean oil. 8. The method of claim 1 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 20 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 9. The method of claim 8 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 10 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 10. The method of claim 1 , wherein the fatty acid-containing monoglycerides are obtained by enzymatic hydrolysis of lard, tallow, or combinations thereof. 11. The method of claim 1 , wherein from 85% to 100% of the fatty acids in the fatty acid-containing monoglycerides are at the Sn-1 position. 12. The method of claim 11 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 13. A method of improving tolerance related to feeding in an infant, the method comprising administering to the infant an infant formula comprising a fat system having at least 10 wt %, by weight of the fat system, of at least one of a fatty acid component, fatty acid-containing monoglycerides having at least 70% of the fatty acids at the Sn-1 position, and combinations thereof, wherein the fatty acid component includes at least one of free fatty acids, fatty acid salts, and combinations thereof. 14. The method of claim 13 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 15. The method of claim 13 , wherein the fatty acid component is in a form selected from the group consisting of calcium fatty acid salts, magnesium fatty acid salts, and combinations thereof. 16. The method of claim 13 , wherein the fatty acid component is derived from a vegetable oil. 17. The method of claim 16 , wherein the vegetable oil comprises at least one of olive oil, canola oil, corn oil, soybean oil, high oleic safflower oil, and combinations thereof. 18. The method of claim 13 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 20 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 19. The method of claim 13 , wherein from 85% to 100% of the fatty acids in the fatty acid-containing monoglycerides are at the Sn-1 position. 20. The method of claim 19 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate.
Nutrients, e.g. vitamins, minerals · CPC title
Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia · CPC title
Drugs for disorders of the alimentary tract or the digestive system · CPC title
Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title
Fatty acids or derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.